BFK — Pharmesis International Cashflow Statement
0.000.00%
Last trade - 00:00- SG$13.63m
- SG$15.70m
- CNY67.65m
Annual cashflow statement for Pharmesis International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.84 | 2.12 | -3.16 | -4.86 | 8.44 |
| Depreciation | |||||
| Non-Cash Items | 1.8 | 1.04 | 1.13 | 4.57 | -5.86 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.91 | -4.35 | 6.59 | -13.1 | -7.56 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.69 | 0.653 | 6.56 | -11.6 | -3.07 |
| Capital Expenditures | -0.918 | -1.58 | -0.238 | -0.656 | -1.17 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | 0.02 | 0.081 | -2.63 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.918 | -1.58 | -0.218 | -0.575 | -3.8 |
| Financing Cash Flow Items | — | — | — | 2.13 | 2.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.274 | -0.282 | -0.604 | 1.91 | 1.99 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.499 | -1.21 | 5.74 | -10.2 | -4.87 |